← Back to Search

Ban & Tailored Pamphlet & Intervention for Smoking (AFV Trial)

N/A
Waitlist Available
Led By Gerald W. Talcott, Ph.D.
Research Sponsored by University of Tennessee
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 month follow-up
Awards & highlights

Summary

The prevalence of tobacco use in the military is too high. This study is designed to take advantage of the 8.5 weeks of forced tobacco cessation during Basic Military Training and develop effective interventions to prevent tobacco relapse. Hypotheses or Research Questions: * Are there differences in the rate of relapse between three groups participating in a tobacco abstinence maintenance intervention? * Do the tobacco abstinence maintenance interventions delay relapse?

Eligible Conditions
  • Smoking
  • Smoking Cessation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Smoking cessation maintenance
Secondary study objectives
Delayed relapse among those who relapse to tobacco use

Trial Design

3Treatment groups
Experimental Treatment
Group I: Ban & Tailored Pamphlet & InterventionExperimental Treatment3 Interventions
After 8.5 weeks of tobacco use cessation during Basic Military Training subjects are provided a tailored relapse prevention pamphlet inspired by Forever Free and tailored for use in the United States Air Force. In addition they are given a face to face relapse prevention intervention.
Group II: Ban & Tailored PamphletExperimental Treatment2 Interventions
After 8.5 weeks of tobacco use cessation during Basic Military Training subjects are provided a tailored relapse prevention pamphlet inspired by Forever Free and tailored for use in the United States Air Force
Group III: Ban & Informational PamphletExperimental Treatment2 Interventions
Following 8.5 weeks of cessation subjects are given an informational pamphlet on tobacco cessation and relapse prevention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Informational Pamphlet
2019
N/A
~170

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,889 Previous Clinical Trials
47,811,207 Total Patients Enrolled
21 Trials studying Smoking
19,767 Patients Enrolled for Smoking
United States Air ForceFED
19 Previous Clinical Trials
29,181 Total Patients Enrolled
University of MinnesotaOTHER
1,413 Previous Clinical Trials
1,538,403 Total Patients Enrolled
11 Trials studying Smoking
5,348 Patients Enrolled for Smoking
~1605 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top